Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab’s Place in COVID-19 Pneumonia

被引：0
|
作者：
Timothée Klopfenstein
Vincent Gendrin
Aurélie Gerazime
Thierry Conrozier
Jean-Charles Balblanc
Pierre-Yves Royer
Anne Lohse
Chaouki Mezher
Lynda Toko
Cerise Guillochon
Julio Badie
Alix Pierron
N.’dri Juliette Kadiane-Oussou
Marc Puyraveau
Souheil Zayet
机构：
[1] Nord Franche-Comté Hospital,Infectious Disease Department
[2] Jean-Minjoz University Hospital,Methodology Unit, Clinical Investigation Center INSERM 1431
[3] Nord Franche-Comté Hospital,Rheumatology Department
[4] Nord Franche-Comté Hospital,Intensive Care Unit Department
来源：
Infectious Diseases and Therapy | 2021年 / 10卷
关键词：
Coronavirus disease 2019; Meta-analysis; Randomized clinical trial; Review; Tocilizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1195 / 1213
页数：18
相关论文
共 50 条
  • [41] Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
    Tleyjeh, Imad M.
    Kashour, Zakariya
    Damlaj, Moussab
    Riaz, Muhammad
    Tlayjeh, Haytham
    Altannir, Mustafa
    Altannir, Youssef
    Al-Tannir, Mohamad
    Tleyjeh, Rana
    Hassett, Leslie
    Kashour, Tarek
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (02) : 215 - 227
  • [42] Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis
    Piscoya, Alejandro
    Parra del Riego, Angela
    Cerna-Viacava, Renato
    Rocco, Jonathon
    Roman, Yuani M.
    Escobedo, Angel A.
    Pasupuleti, Vinay
    White, C. Michael
    Hernandez, Adrian, V
    PLOS ONE, 2022, 17 (06):
  • [43] Effectiveness of tocilizumab in the treatment of hospitalized adults COVID-19 A systematic review and meta-analysis
    Zhang, Jing
    Chen, Chun
    Yang, Yi
    Yang, Jin
    MEDICINE, 2022, 101 (09) : E28967
  • [44] Beneficial and harmful outcomes of tocilizumab in severe COVID-19: A systematic review and meta-analysis
    Rubio-Rivas, Manuel
    Forero, Carlos G.
    Maria Mora-Lujan, Jose
    Montero, Abelardo
    Formiga, Francesc
    Homs, Narcis A.
    Alba-Albalate, Joan
    Sanchez, Laura
    Rello, Jordi
    Corbella, Xavier
    PHARMACOTHERAPY, 2021, 41 (11): : 884 - 906
  • [45] Efficacy and safety of Tocilizumab in severe and critical COVID-19: A Systematic Review and Meta-Analysis
    Rezaei, Soheila
    Fatemi, Behzad
    Karimi Majd, Zahra
    Minaei, Hossein
    Peikanpour, Mohammad
    Anjidani, Nassim
    Taheri, Ali
    Dastan, Farzaneh
    Mosaed, Reza
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (05) : 499 - 511
  • [46] Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials
    Vijairam Selvaraj
    Mohammad Saud Khan
    Chirag Bavishi
    Kwame Dapaah-Afriyie
    Arkadiy Finn
    Amos Lal
    Eleftherios Mylonakis
    Lung, 2021, 199 : 239 - 248
  • [47] Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials
    Selvaraj, Vijairam
    Khan, Mohammad Saud
    Bavishi, Chirag
    Dapaah-Afriyie, Kwame
    Finn, Arkadiy
    Lal, Amos
    Mylonakis, Eleftherios
    LUNG, 2021, 199 (03) : 239 - 248
  • [48] Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials
    Snow, Timothy Arthur Chandos
    Saleem, Naveed
    Ambler, Gareth
    Nastouli, Eleni
    Singer, Mervyn
    Arulkumaran, Nishkantha
    INTENSIVE CARE MEDICINE, 2021, 47 (06) : 641 - 652
  • [49] Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials
    Timothy Arthur Chandos Snow
    Naveed Saleem
    Gareth Ambler
    Eleni Nastouli
    Mervyn Singer
    Nishkantha Arulkumaran
    Intensive Care Medicine, 2021, 47 : 641 - 652
  • [50] The role of Chinese medicine in COVID-19 pneumonia: A systematic review and meta-analysis
    Sun, Chun-Yang
    Sun, Ya-Lei
    Li, Xin-Min
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2020, 38 (10): : 2153 - 2159
12345